Thrombotic thrombocytopenic purpura surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Thrombotic thrombocytopenic purpura medical therapy}} | ||
{{CMG}}; {{AE}} {{S.G.}} | {{CMG}}; {{AE}} {{S.G.}} | ||
Revision as of 16:23, 5 October 2018
Template:Thrombotic thrombocytopenic purpura medical therapy Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
The mainstay of treatment for TTP is medical therapy. Surgery is usually reserved for patients with either no cure with plasma treatments and medicines.
Indications
- Surgery is not the first-line treatment option for patients withTTP when plasma treatments and medicines do not cure TTP, surgury is needed.[1]
Surgery
- Surgery is not the first-line treatment option for patients withTTP. Sometimes spelenectomy is needed, because the antibodies is made by cell in spleen that block ADAMTS13 enzyme activity.